Elevated blood markers 1 year before manifestation of malignant glioma

We detected distinct plasma concentration profiles of S100B, neuropeptide Y, and secretagogin in 3 of 191 patients enrolled in a previous study investigating brain-tissue-related markers in the blood of patients with atrial fibrillation. Intriguingly, 2 of these 3 patients, both of whom were without...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2010-09, Vol.12 (9), p.1004-1008
Hauptverfasser: Gartner, Wolfgang, Ilhan, Aysegül, Neziri, Dashurie, Base, Wolfgang, Weissel, Michael, Wöhrer, Adelheid, Heinzl, Harald, Waldhör, Thomas, Wagner, Ludwig, Preusser, Matthias
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1008
container_issue 9
container_start_page 1004
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 12
creator Gartner, Wolfgang
Ilhan, Aysegül
Neziri, Dashurie
Base, Wolfgang
Weissel, Michael
Wöhrer, Adelheid
Heinzl, Harald
Waldhör, Thomas
Wagner, Ludwig
Preusser, Matthias
description We detected distinct plasma concentration profiles of S100B, neuropeptide Y, and secretagogin in 3 of 191 patients enrolled in a previous study investigating brain-tissue-related markers in the blood of patients with atrial fibrillation. Intriguingly, 2 of these 3 patients, both of whom were without neurological symptoms at the time of blood sampling, were diagnosed with malignant glioma (MG) approximately 1 year later. To our knowledge, this is the first report indicating that distinct blood biomarker profiles may be detected long before clinical manifestation of MG.
doi_str_mv 10.1093/neuonc/noq034
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2940699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/neuonc/noq034</oup_id><sourcerecordid>748965488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-7634287dbf694b35f70512e2e8b3faaa4347390c3f00d78cae9a2375e390fa663</originalsourceid><addsrcrecordid>eNqFkDlPxDAQhS0E4lgoaVE6aML6io8GCa24JCQaqC0nGS-BrL3YCRL_HkMAQUU1ozef3sw8hA4JPiVYs7mHMfhm7sMLZnwD7ZKKsrJSQmx-9rRUFZE7aC-lJ4wpqQTZRjsUM6mEUrvo8qKHVztAW9R9CG2xsvEZYipI8QY2FjW4ECGrvnOQBjt0wRfBZaHvlt76oVj2XVjZfbTlbJ_g4KvO0MPlxf3iury9u7pZnN-WDSd6KKVgnCrZ1k5oXrPKSVwRChRUzZy1ljMumcYNcxi3UjUWtKVMVpBFZ4VgM3Q2-a7HegVtA36Itjfr2OXD30ywnfk78d2jWYZXQzXHQutscPxlEMPLmF8yqy410PfWQxiTkVxpUXGlMllOZBNDShHczxaCzUf0ZoreTNFn_uj3aT_0d9YZOJmAMK7_8XoHEguQrw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748965488</pqid></control><display><type>article</type><title>Elevated blood markers 1 year before manifestation of malignant glioma</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Gartner, Wolfgang ; Ilhan, Aysegül ; Neziri, Dashurie ; Base, Wolfgang ; Weissel, Michael ; Wöhrer, Adelheid ; Heinzl, Harald ; Waldhör, Thomas ; Wagner, Ludwig ; Preusser, Matthias</creator><creatorcontrib>Gartner, Wolfgang ; Ilhan, Aysegül ; Neziri, Dashurie ; Base, Wolfgang ; Weissel, Michael ; Wöhrer, Adelheid ; Heinzl, Harald ; Waldhör, Thomas ; Wagner, Ludwig ; Preusser, Matthias</creatorcontrib><description>We detected distinct plasma concentration profiles of S100B, neuropeptide Y, and secretagogin in 3 of 191 patients enrolled in a previous study investigating brain-tissue-related markers in the blood of patients with atrial fibrillation. Intriguingly, 2 of these 3 patients, both of whom were without neurological symptoms at the time of blood sampling, were diagnosed with malignant glioma (MG) approximately 1 year later. To our knowledge, this is the first report indicating that distinct blood biomarker profiles may be detected long before clinical manifestation of MG.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noq034</identifier><identifier>PMID: 20378688</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Atrial Fibrillation - blood ; Biomarkers, Tumor - blood ; Brain Neoplasms - blood ; Calcium-Binding Proteins - blood ; Female ; Glioma - blood ; Humans ; Male ; Middle Aged ; Nerve Growth Factors - blood ; Neuropeptide Y - blood ; Reviews ; S100 Calcium Binding Protein beta Subunit ; S100 Proteins - blood ; Secretagogins ; Young Adult</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2010-09, Vol.12 (9), p.1004-1008</ispartof><rights>The Author(s) 2010. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org. 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-7634287dbf694b35f70512e2e8b3faaa4347390c3f00d78cae9a2375e390fa663</citedby><cites>FETCH-LOGICAL-c419t-7634287dbf694b35f70512e2e8b3faaa4347390c3f00d78cae9a2375e390fa663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940699/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940699/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1584,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20378688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gartner, Wolfgang</creatorcontrib><creatorcontrib>Ilhan, Aysegül</creatorcontrib><creatorcontrib>Neziri, Dashurie</creatorcontrib><creatorcontrib>Base, Wolfgang</creatorcontrib><creatorcontrib>Weissel, Michael</creatorcontrib><creatorcontrib>Wöhrer, Adelheid</creatorcontrib><creatorcontrib>Heinzl, Harald</creatorcontrib><creatorcontrib>Waldhör, Thomas</creatorcontrib><creatorcontrib>Wagner, Ludwig</creatorcontrib><creatorcontrib>Preusser, Matthias</creatorcontrib><title>Elevated blood markers 1 year before manifestation of malignant glioma</title><title>Neuro-oncology (Charlottesville, Va.)</title><addtitle>Neuro Oncol</addtitle><description>We detected distinct plasma concentration profiles of S100B, neuropeptide Y, and secretagogin in 3 of 191 patients enrolled in a previous study investigating brain-tissue-related markers in the blood of patients with atrial fibrillation. Intriguingly, 2 of these 3 patients, both of whom were without neurological symptoms at the time of blood sampling, were diagnosed with malignant glioma (MG) approximately 1 year later. To our knowledge, this is the first report indicating that distinct blood biomarker profiles may be detected long before clinical manifestation of MG.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Atrial Fibrillation - blood</subject><subject>Biomarkers, Tumor - blood</subject><subject>Brain Neoplasms - blood</subject><subject>Calcium-Binding Proteins - blood</subject><subject>Female</subject><subject>Glioma - blood</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nerve Growth Factors - blood</subject><subject>Neuropeptide Y - blood</subject><subject>Reviews</subject><subject>S100 Calcium Binding Protein beta Subunit</subject><subject>S100 Proteins - blood</subject><subject>Secretagogins</subject><subject>Young Adult</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDlPxDAQhS0E4lgoaVE6aML6io8GCa24JCQaqC0nGS-BrL3YCRL_HkMAQUU1ozef3sw8hA4JPiVYs7mHMfhm7sMLZnwD7ZKKsrJSQmx-9rRUFZE7aC-lJ4wpqQTZRjsUM6mEUrvo8qKHVztAW9R9CG2xsvEZYipI8QY2FjW4ECGrvnOQBjt0wRfBZaHvlt76oVj2XVjZfbTlbJ_g4KvO0MPlxf3iury9u7pZnN-WDSd6KKVgnCrZ1k5oXrPKSVwRChRUzZy1ljMumcYNcxi3UjUWtKVMVpBFZ4VgM3Q2-a7HegVtA36Itjfr2OXD30ywnfk78d2jWYZXQzXHQutscPxlEMPLmF8yqy410PfWQxiTkVxpUXGlMllOZBNDShHczxaCzUf0ZoreTNFn_uj3aT_0d9YZOJmAMK7_8XoHEguQrw</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Gartner, Wolfgang</creator><creator>Ilhan, Aysegül</creator><creator>Neziri, Dashurie</creator><creator>Base, Wolfgang</creator><creator>Weissel, Michael</creator><creator>Wöhrer, Adelheid</creator><creator>Heinzl, Harald</creator><creator>Waldhör, Thomas</creator><creator>Wagner, Ludwig</creator><creator>Preusser, Matthias</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100901</creationdate><title>Elevated blood markers 1 year before manifestation of malignant glioma</title><author>Gartner, Wolfgang ; Ilhan, Aysegül ; Neziri, Dashurie ; Base, Wolfgang ; Weissel, Michael ; Wöhrer, Adelheid ; Heinzl, Harald ; Waldhör, Thomas ; Wagner, Ludwig ; Preusser, Matthias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-7634287dbf694b35f70512e2e8b3faaa4347390c3f00d78cae9a2375e390fa663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Atrial Fibrillation - blood</topic><topic>Biomarkers, Tumor - blood</topic><topic>Brain Neoplasms - blood</topic><topic>Calcium-Binding Proteins - blood</topic><topic>Female</topic><topic>Glioma - blood</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nerve Growth Factors - blood</topic><topic>Neuropeptide Y - blood</topic><topic>Reviews</topic><topic>S100 Calcium Binding Protein beta Subunit</topic><topic>S100 Proteins - blood</topic><topic>Secretagogins</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gartner, Wolfgang</creatorcontrib><creatorcontrib>Ilhan, Aysegül</creatorcontrib><creatorcontrib>Neziri, Dashurie</creatorcontrib><creatorcontrib>Base, Wolfgang</creatorcontrib><creatorcontrib>Weissel, Michael</creatorcontrib><creatorcontrib>Wöhrer, Adelheid</creatorcontrib><creatorcontrib>Heinzl, Harald</creatorcontrib><creatorcontrib>Waldhör, Thomas</creatorcontrib><creatorcontrib>Wagner, Ludwig</creatorcontrib><creatorcontrib>Preusser, Matthias</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gartner, Wolfgang</au><au>Ilhan, Aysegül</au><au>Neziri, Dashurie</au><au>Base, Wolfgang</au><au>Weissel, Michael</au><au>Wöhrer, Adelheid</au><au>Heinzl, Harald</au><au>Waldhör, Thomas</au><au>Wagner, Ludwig</au><au>Preusser, Matthias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated blood markers 1 year before manifestation of malignant glioma</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><addtitle>Neuro Oncol</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>12</volume><issue>9</issue><spage>1004</spage><epage>1008</epage><pages>1004-1008</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>We detected distinct plasma concentration profiles of S100B, neuropeptide Y, and secretagogin in 3 of 191 patients enrolled in a previous study investigating brain-tissue-related markers in the blood of patients with atrial fibrillation. Intriguingly, 2 of these 3 patients, both of whom were without neurological symptoms at the time of blood sampling, were diagnosed with malignant glioma (MG) approximately 1 year later. To our knowledge, this is the first report indicating that distinct blood biomarker profiles may be detected long before clinical manifestation of MG.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>20378688</pmid><doi>10.1093/neuonc/noq034</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2010-09, Vol.12 (9), p.1004-1008
issn 1522-8517
1523-5866
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2940699
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adolescent
Adult
Aged
Aged, 80 and over
Atrial Fibrillation - blood
Biomarkers, Tumor - blood
Brain Neoplasms - blood
Calcium-Binding Proteins - blood
Female
Glioma - blood
Humans
Male
Middle Aged
Nerve Growth Factors - blood
Neuropeptide Y - blood
Reviews
S100 Calcium Binding Protein beta Subunit
S100 Proteins - blood
Secretagogins
Young Adult
title Elevated blood markers 1 year before manifestation of malignant glioma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A53%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20blood%20markers%201%20year%20before%20manifestation%20of%20malignant%20glioma&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Gartner,%20Wolfgang&rft.date=2010-09-01&rft.volume=12&rft.issue=9&rft.spage=1004&rft.epage=1008&rft.pages=1004-1008&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noq034&rft_dat=%3Cproquest_pubme%3E748965488%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748965488&rft_id=info:pmid/20378688&rft_oup_id=10.1093/neuonc/noq034&rfr_iscdi=true